169 related articles for article (PubMed ID: 3337297)
1. Response of psychotic and nonpsychotic depression to phenelzine.
Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
[TBL] [Abstract][Full Text] [Related]
2. MAO inhibition and clinical response in depressed patients treated with phenelzine.
Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
[TBL] [Abstract][Full Text] [Related]
3. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
Chan CH; Janicak PG; Davis JM; Altman E; Andriukaitis S; Hedeker D
J Clin Psychiatry; 1987 May; 48(5):197-200. PubMed ID: 3571174
[TBL] [Abstract][Full Text] [Related]
4. Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
Kocsis JH; Croughan JL; Katz MM; Butler TP; Secunda S; Bowden CL; Davis JM
Am J Psychiatry; 1990 May; 147(5):621-4. PubMed ID: 2183635
[TBL] [Abstract][Full Text] [Related]
5. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Georgotas A; McCue RE; Friedman E; Cooper T
Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
[TBL] [Abstract][Full Text] [Related]
7. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
[TBL] [Abstract][Full Text] [Related]
8. Phenelzine treatment of melancholia.
McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
[TBL] [Abstract][Full Text] [Related]
9. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
[TBL] [Abstract][Full Text] [Related]
10. Differential response patterns to MAO inhibitors and tricyclics.
Nies A
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
[TBL] [Abstract][Full Text] [Related]
11. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
[TBL] [Abstract][Full Text] [Related]
12. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R
J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467
[TBL] [Abstract][Full Text] [Related]
13. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
Raft D; Davidson J; Wasik J; Mattox A
Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
[TBL] [Abstract][Full Text] [Related]
14. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
[TBL] [Abstract][Full Text] [Related]
15. MAOIs in the contemporary treatment of depression.
Thase ME; Trivedi MH; Rush AJ
Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
[TBL] [Abstract][Full Text] [Related]
16. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
[TBL] [Abstract][Full Text] [Related]
17. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
Feighner JP; Herbstein J; Damlouji N
J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
[TBL] [Abstract][Full Text] [Related]
18. Phenelzine for chronic depression: a study of continuation treatment.
Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
[TBL] [Abstract][Full Text] [Related]
19. First results on the effects of MAO inhibition on cognitive functioning in elderly depressed patients.
Georgotas A; Reisberg B; Ferris S
Arch Gerontol Geriatr; 1983 Nov; 2(3):249-54. PubMed ID: 6651397
[TBL] [Abstract][Full Text] [Related]
20. A comparison of phenelzine and imipramine in depressed inpatients.
Davidson JR; McLeod MN; Turnbull CD; Miller RD
J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
